2026 Med Spa Industry Growth Rate

Updated May 2026 · Research period: January–May 2026

From January through May 2026, the Spakinect research team tracked and analyzed Med Spa industry benchmarks from across the United States. The figures below cover market size, location growth, service revenue distribution, patient demographics, and the compliance trends shaping how practices compete in 2026.

The 2026 Med Spa Industry Growth Rate

The U.S. Med Spa sector has sustained double-digit annual growth for over a decade, fueled by rising consumer demand for non-surgical aesthetic treatments, growing disposable incomes, and an expanding provider base. The table below compiles verified benchmarks and modeled estimates to document the industry’s trajectory from 2017 through 2033.

Note: All market size figures are standardized to Grand View Research (GVR) data to ensure consistent methodology and regional alignment. U.S.-only market size is consistently estimated at approximately 38.4% of the global market, in line with North America’s regional share. Historical location counts (2017–2023) are sourced from AmSpa and AMB Wealth.

Three insights can be drawn from this data:

• The U.S. Med Spa market increased in location count between 2017 and 2023, growing from 4,200 to 10,488 facilities, a 150% increase in six years with no evidence of market saturation.
• The global Med Spa market is projected to grow from $21.21B in 2024 to $78.23B by 2033, a CAGR of 15.77% over that window (Research and Markets), one of the highest sustained growth rates in any consumer healthcare segment.
• U.S. industry revenue is growing by more than $1 billion per year, with 84% of Med Spa owners projecting revenue increases and 54% of those expecting gains of at least 10%.

U.S. Med Spa Location Growth by State and Ownership Type

Geographic concentration in the U.S. Med Spa market is significant, with four states accounting for over 38% of all Med Spa businesses. The ownership landscape remains highly fragmented, creating both compliance risk and consolidation opportunity. The table below documents the current distribution.

• The Med Spa sector remains one of the most fragmented in consumer healthcare, with 81% of facilities independently owned, which means compliance responsibility falls on individual owners.
• Multi-location operators are scaling rapidly, averaging nine locations per group in 2024, up from six in 2022, a 50% increase in group size over two years that signals accelerating consolidation pressure.
• 18% of active Med Spas opened within the prior year as of 2023, meaning a substantial share of U.S. operators are first-year owners entering a market that requires compliance infrastructure, including Good Faith Exam protocols, from day one.

Med Spa Revenue by Service Category in 2026

Injectables continue to anchor Med Spa revenue across the U.S., though body contouring and wellness services are growing at a faster pace. The tables below present revenue share by category alongside average procedure costs and the share of facilities offering each service type.

• Neurotoxins and dermal fillers capture 53 cents of every revenue dollar spent at Med Spas, a dominance that has held steady for years.
• Botulinum toxin procedures surpassed 9 million treatments in the U.S. in 2023 (ASPS), with demand increasing by nearly 500% since 2000.
• Body shaping and contouring is the fastest-growing service segment, driven by advances in non-invasive technology, including cryolipolysis, radiofrequency, and laser systems, and by growing consumer demand for results without surgical recovery time.

Patient Demographics and Spending Patterns in 2026

The Med Spa patient base is demographically distinct and highly loyal. The data below captures the spending behaviors and demographic profile of the active U.S. Med Spa patient, drawn from AmSpa’s 2024 State of the Industry Report and supplemental industry analysis.

• The repeat patient rate rose 8 points, from 65% to 73% between 2022 and 2024, indicating that Med Spa treatments are transitioning from discretionary purchases to routine wellness behaviors for a growing share of the U.S. adult population.
• The 55+ female patient segment posted the largest share gain of any age cohort, rising from 21% to 24% of female patients in two years, reflecting an aging population with growing interest in restorative procedures and the highest average disposable income of any Med Spa demographic.
• Average revenue per location grew 6.97% year-over-year to $1,398,833 in 2024, even as the total number of U.S. locations grew approximately 6%. Both supply and per-location revenue grew simultaneously, which means patient demand is still outpacing supply.

Med Spa Compliance Landscape and Business Structure 2026

As the Med Spa sector grows, regulatory complexity has grown proportionally. Good Faith Exam requirements, medical director oversight mandates, and state-level Corporate Practice of Medicine (CPOM) each require specific documentation. The table below outlines the structural and compliance indicators that define the current operating environment for U.S. Med Spas.

Regulatory Considerations in the Top 4 Med Spa States

Regulatory requirements vary significantly depending on where your practice operates. The table below outlines the key compliance factors across the four states with the highest Med Spa concentration.

• 74% of medical directors at U.S. Med Spas now come from non-core specialties, up from 69% in 2022. As practitioners from family medicine and nursing increasingly direct aesthetic practices, third-party GFE compliance support becomes a more practical solution than relying on in-house documentation alone.
• 48% of Med Spas hired a new medical director within the past year. Outsourcing Good Faith Exams to a W-2 provider network removes any documentation gaps from your risk profile entirely.

This report was compiled by Spakinect from platform data across 4,500+ active Med Spas and aggregated public industry benchmarks.